Sequoia Wealth Management’s AbbVie ABBV Stock Holding History

Sequoia Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,121	Closed	-$250K	–	53
2019 Q1	$250K	Sell	3,121 -142	-4%	-$11.6K	0.2%	65
2018 Q4	$301K	Buy	3,263 +3	+0.1%	+$264	0.3%	49
2018 Q3	$309K	Sell	3,260 -441	-12%	-$41.8K	0.27%	47
2018 Q2	$308K	Buy	3,701 +271	+8%	+$26.5K	0.33%	45
2018 Q1	$325K	Buy	3,430 +12	+0.4%	+$1.32K	0.31%	43
2017 Q4	$340K	Buy	+3,418	New	+$322K	0.31%	42

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Sequoia Wealth Management's ABBV Position: Q2 2019 in Review

Sequoia Wealth Management sold out of AbbVie (ABBV) in Q2 2019, closing a stake of 3,121 shares — an estimated $250K sold.

Sequoia Wealth Management first reported a position in ABBV in Q4 2017 and held it in 6 quarters. The position peaked at $340K in Q4 2017. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

Sequoia Wealth Management reported no remaining AbbVie position as of Q2 2019 after selling out during the quarter.
Sequoia Wealth Management sold 3,121 AbbVie shares in Q2 2019, an estimated $250K.
Sequoia Wealth Management first reported a position in AbbVie in Q4 2017 and held it in 6 quarters.
Sequoia Wealth Management's AbbVie position peaked at $340K in Q4 2017.
2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Sequoia Wealth Management's 13F filing for Q2 2019, filed 6 Aug 2019.